DK0610336T3 - Behandling af neurologiske tilstande ved hjælp af en interleukin-1-hæmmende forbindelse - Google Patents
Behandling af neurologiske tilstande ved hjælp af en interleukin-1-hæmmende forbindelseInfo
- Publication number
- DK0610336T3 DK0610336T3 DK92922537T DK92922537T DK0610336T3 DK 0610336 T3 DK0610336 T3 DK 0610336T3 DK 92922537 T DK92922537 T DK 92922537T DK 92922537 T DK92922537 T DK 92922537T DK 0610336 T3 DK0610336 T3 DK 0610336T3
- Authority
- DK
- Denmark
- Prior art keywords
- interleukin
- treatment
- pct
- inhibitory compound
- neurological conditions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919123161A GB9123161D0 (en) | 1991-10-31 | 1991-10-31 | Treatment of neurological conditions |
GB919125670A GB9125670D0 (en) | 1991-11-30 | 1991-11-30 | Treatment of neurogical conditions |
PCT/GB1992/002023 WO1993008820A1 (en) | 1991-10-31 | 1992-11-02 | Treatment of neurological conditions by an interleukin-1 inhibiting compound |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0610336T3 true DK0610336T3 (da) | 2002-07-22 |
Family
ID=26299779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92922537T DK0610336T3 (da) | 1991-10-31 | 1992-11-02 | Behandling af neurologiske tilstande ved hjælp af en interleukin-1-hæmmende forbindelse |
Country Status (10)
Country | Link |
---|---|
US (1) | US6090775A (da) |
EP (1) | EP0610336B1 (da) |
JP (1) | JP3623501B2 (da) |
AT (1) | ATE214939T1 (da) |
AU (3) | AU2884592A (da) |
CA (1) | CA2122596C (da) |
DE (1) | DE69232516T2 (da) |
DK (1) | DK0610336T3 (da) |
ES (1) | ES2173871T3 (da) |
WO (2) | WO1993008819A1 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6159460A (en) * | 1988-05-27 | 2000-12-12 | Amgen Inc. | Method for treating interleukin-1 mediated diseases |
US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
US6858409B1 (en) | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
ATE270550T1 (de) * | 1995-04-07 | 2004-07-15 | Teijin Ltd | Wirkstoff zum schutz für organ oder gewebe |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US20030040660A1 (en) * | 2001-08-27 | 2003-02-27 | George Jackowski | Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein |
WO2003022213A2 (en) * | 2001-09-06 | 2003-03-20 | Board Of Regents, The University Of Texas System | Therapeutic treatments for spinal cord injury via blockade of interleukin-1 receptor |
EP1863847A2 (en) * | 2004-12-02 | 2007-12-12 | Domantis Limited | Anti-il-1r1 single domain antibodies and therapeutic uses |
BRPI0619224A2 (pt) * | 2005-12-01 | 2017-06-20 | Domantis Ltd | monômero de anticorpo de domínio, ligando, ácidos nucleicos isolado e recombinante, vetor, célula hospedeira, método para produzir um monômero de dab de ligando, composição farmacêutica, dispositivo de liberação de medicamento, uso de um monômero de anticorpo de domínio, e, método para tratar uma doença inflamatória, artrite ou doença respiratória |
AU2010203425B2 (en) * | 2009-01-09 | 2015-04-09 | The Schepens Eye Research Institute, Inc. | Therapeutic compositions for treatment of corneal disorders |
EP2598526B1 (en) | 2010-07-29 | 2018-09-05 | Eleven Biotherapeutics, Inc. | Chimeric il-1 receptor type i agonists and antagonists |
DK2968468T3 (en) | 2013-03-13 | 2021-07-26 | Buzzard Pharmaceuticals AB | Chimeric cytokine formulations for ocular delivery |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965271A (en) * | 1986-12-31 | 1990-10-23 | Hoechst Roussel Pharmaceuticals, Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
IL100535A (en) * | 1986-12-31 | 1994-05-30 | Hoechst Roussel Pharma | Pharmaceutical preparations containing a history of xanthine to relieve disease states |
HU203198B (en) * | 1987-10-26 | 1991-06-28 | Sandoz Ag | Process for producing pharmaceutical compositions having immunity-inhibiting, monokin-, particularly interleukin-1-inhibiting effect |
AU5921890A (en) * | 1989-06-13 | 1991-01-08 | Smithkline Beecham Corporation | Monokine activity interference |
AU649245B2 (en) * | 1990-04-02 | 1994-05-19 | Amgen, Inc. | Methods for treating interleukin-1 mediated diseases |
-
1992
- 1992-11-02 CA CA002122596A patent/CA2122596C/en not_active Expired - Lifetime
- 1992-11-02 AU AU28845/92A patent/AU2884592A/en not_active Abandoned
- 1992-11-02 DK DK92922537T patent/DK0610336T3/da active
- 1992-11-02 JP JP50826093A patent/JP3623501B2/ja not_active Expired - Lifetime
- 1992-11-02 ES ES92922537T patent/ES2173871T3/es not_active Expired - Lifetime
- 1992-11-02 EP EP92922537A patent/EP0610336B1/en not_active Expired - Lifetime
- 1992-11-02 US US08/232,167 patent/US6090775A/en not_active Expired - Lifetime
- 1992-11-02 WO PCT/GB1992/002019 patent/WO1993008819A1/en active Application Filing
- 1992-11-02 WO PCT/GB1992/002023 patent/WO1993008820A1/en active IP Right Grant
- 1992-11-02 AT AT92922537T patent/ATE214939T1/de not_active IP Right Cessation
- 1992-11-02 DE DE69232516T patent/DE69232516T2/de not_active Expired - Lifetime
- 1992-11-02 AU AU28041/92A patent/AU2804192A/en not_active Abandoned
-
1996
- 1996-12-24 AU AU76482/96A patent/AU7648296A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6090775A (en) | 2000-07-18 |
AU7648296A (en) | 1997-02-13 |
JPH07505608A (ja) | 1995-06-22 |
WO1993008820A1 (en) | 1993-05-13 |
EP0610336B1 (en) | 2002-03-27 |
JP3623501B2 (ja) | 2005-02-23 |
DE69232516D1 (de) | 2002-05-02 |
ES2173871T3 (es) | 2002-11-01 |
ATE214939T1 (de) | 2002-04-15 |
WO1993008819A1 (en) | 1993-05-13 |
AU2804192A (en) | 1993-06-07 |
CA2122596C (en) | 2008-06-03 |
CA2122596A1 (en) | 1993-05-13 |
EP0610336A1 (en) | 1994-08-17 |
DE69232516T2 (de) | 2002-10-31 |
AU2884592A (en) | 1993-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
DK0610336T3 (da) | Behandling af neurologiske tilstande ved hjælp af en interleukin-1-hæmmende forbindelse | |
SE9604793D0 (sv) | New polymorphs | |
DE69904576D1 (de) | Zur behandlung von cmv infektionen geeignete 1,3,4-thiadiazole | |
DK1334731T3 (da) | Forebyggende eller terapeutisk middel mod psoriasis omfattende anti-IL-6-receptorantistof som aktiv bestanddel | |
DK0897726T3 (da) | Antipruritisk middel | |
NO20012977L (no) | N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet | |
DK0641328T3 (da) | Broforbundne, azabicykliske derivater som substans P-antagonister | |
ATE184594T1 (de) | Sulfonamidderivate als aspartylprotease- inhibitoren | |
ES2108120T3 (es) | Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf. | |
DE59400489D1 (de) | Fungizide Wirkstoffkombinationen | |
PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
DK0772603T3 (da) | Substituerede pyrimidinforbindelser og deres anvendelse | |
BR9606547A (pt) | Novos derivados de pirimidona com atividade fungicida | |
BR0113590A (pt) | 7-oxo-piridopirimidinas | |
ES2134801T3 (es) | Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso. | |
AU7713891A (en) | Use of substituted 1,2,4-triazinediones | |
ATE332145T1 (de) | Arzneien zur begleitenden behandlung von glaukomen | |
KR910004191A (ko) | 신질환치료제 | |
DK0935461T3 (da) | Adamantanaminderivater til bekæmpelse af virus fra Borna viridae familien | |
TR199701497T1 (xx) | Beyin �demini �nleyen terkip. | |
ITMI920955A1 (it) | Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili | |
HU0201394D0 (da) | ||
MX9304075A (es) | Composicion farmaceutica para el tratamiento o profilaxis de los desordenes trombohemorragicos consuntivos. | |
FI953002A (fi) | Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla |